BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26925822)

  • 1. Long-term Use of Systemic Treatments for Moderate-to-Severe Atopic Dermatitis in Adults: A Monocentric Retrospective Study.
    Védie AL; Ezzedine K; Amazan E; Boralevi F; Milpied B; Taïeb A; Seneschal J
    Acta Derm Venereol; 2016 Aug; 96(6):802-6. PubMed ID: 26925822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review.
    Roekevisch E; Spuls PI; Kuester D; Limpens J; Schmitt J
    J Allergy Clin Immunol; 2014 Feb; 133(2):429-38. PubMed ID: 24269258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of methotrexate versus azathioprine for severe atopic eczema.
    Schram ME; Roekevisch E; Leeflang MM; Bos JD; Schmitt J; Spuls PI
    J Allergy Clin Immunol; 2011 Aug; 128(2):353-9. PubMed ID: 21514637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on systemic therapies for atopic dermatitis.
    Denby KS; Beck LA
    Curr Opin Allergy Clin Immunol; 2012 Aug; 12(4):421-6. PubMed ID: 22622476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic therapies for severe atopic dermatitis in children and adults.
    Flohr C; Irvine AD
    J Allergy Clin Immunol; 2013 Sep; 132(3):774-774.e6. PubMed ID: 23993356
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults.
    Lyakhovitsky A; Barzilai A; Heyman R; Baum S; Amichai B; Solomon M; Shpiro D; Trau H
    J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):43-9. PubMed ID: 19552716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres.
    Garritsen FM; Roekevisch E; van der Schaft J; Deinum J; Spuls PI; de Bruin-Weller MS
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1905-12. PubMed ID: 25752497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug survival and postdrug survival of first-line immunosuppressive treatments for atopic dermatitis: comparison between methotrexate and cyclosporine.
    Law Ping Man S; Bouzillé G; Beneton N; Safa G; Dupuy A; Droitcourt C
    J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):1327-1335. PubMed ID: 29444359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey.
    Totri CR; Eichenfield LF; Logan K; Proudfoot L; Schmitt J; Lara-Corrales I; Sugarman J; Tom W; Siegfried E; Cordoro K; Paller AS; Flohr C
    J Am Acad Dermatol; 2017 Feb; 76(2):281-285. PubMed ID: 27855965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of severe atopic dermatitis in children.
    Tan AU; Gonzalez ME
    J Drugs Dermatol; 2012 Oct; 11(10):1158-65. PubMed ID: 23134980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Treatment of Atopic Dermatitis.
    Prezzano JC; Beck LA
    Dermatol Clin; 2017 Jul; 35(3):335-349. PubMed ID: 28577803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial.
    Meggitt SJ; Gray JC; Reynolds NJ
    Lancet; 2006 Mar; 367(9513):839-46. PubMed ID: 16530578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema.
    Zoller L; Ramon M; Bergman R
    Isr Med Assoc J; 2008 Jun; 10(6):413-4. PubMed ID: 18669134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further experience of using azathioprine in the treatment of severe atopic dermatitis.
    Hughes R; Collins P; Rogers S
    Clin Exp Dermatol; 2008 Nov; 33(6):710-1. PubMed ID: 18681884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate for the treatment of adult atopic dermatitis.
    Goujon C; Bérard F; Dahel K; Guillot I; Hennino A; Nosbaum A; Saad N; Nicolas JF
    Eur J Dermatol; 2006; 16(2):155-8. PubMed ID: 16581567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic therapy of atopic dermatitis in children and adults.
    Simon D
    Curr Probl Dermatol; 2011; 41():156-164. PubMed ID: 21576956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usage and effectiveness of systemic treatments in adults with severe atopic eczema: First results of the German Atopic Eczema Registry TREATgermany.
    Schmitt J; Abraham S; Trautmann F; Stephan V; Fölster-Holst R; Homey B; Bieber T; Novak N; Sticherling M; Augustin M; Kleinheinz A; Elsner P; Weidinger S; Werfel T
    J Dtsch Dermatol Ges; 2017 Jan; 15(1):49-59. PubMed ID: 27862987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atopic dermatitis: systemic immunosuppressive therapy.
    Akhavan A; Rudikoff D
    Semin Cutan Med Surg; 2008 Jun; 27(2):151-5. PubMed ID: 18620137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atopic dermatitis: phototherapy and systemic therapy.
    Davis DM; Borok J; Udkoff J; Lio P; Spergel J
    Semin Cutan Med Surg; 2017 Sep; 36(3):118-123. PubMed ID: 28895958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt.
    El-Khalawany MA; Hassan H; Shaaban D; Ghonaim N; Eassa B
    Eur J Pediatr; 2013 Mar; 172(3):351-6. PubMed ID: 23229188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.